Optimizing Your Life Sciences Portfolio Strategy
Geography Matters in Life Sciences
For pharmaceutical companies, investing in the right locations is just as important as investing in the right products. When crafting your real estate footprint and portfolio strategy, it’s crucial to align your geographic choices with your business objectives. Whether your focus is innovation, revenue growth, or improved margins, selecting the right region accelerates success.
Strategic Locations Drive Business Goals
Different geographies offer different advantages. By understanding the role of each location in your broader strategy, you can better support business outcomes, from talent acquisition to risk management.
- Innovation Support – Leading innovation hubs foster R&D breakthroughs.
- Revenue Generation – High GDP countries are prime locations for revenue-driving operations.
- Cost Management – Lower-cost platforms enable efficient, adaptive R&D and operations.
Achieve Your Business Goals with the Right Location
Optimizing your portfolio and footprint strategy can provide immediate benefits. JLL partners with global pharmaceutical companies to leverage real estate as a strategic tool in achieving operational and financial success.
Key Benefits of Strategic Location Selection:
- Cost Management – Use location and occupancy data as strategic levers to reduce costs.
- Talent Acquisition – Access skilled professionals who are aligned with your business needs.
- Risk Mitigation – Avoid or manage regional risks that could impact operations.
- Capacity Allocation – Allocate resources to meet short-term and long-term goals.
- Regulatory Compliance – Ensure your locations meet the required regulatory standards.
Where to Invest?
Understanding how various geographies align with your goals is key to making informed decisions. Below are regions suited for specific business objectives:
- Innovation: Focus on countries like South Korea, Japan, the United States, and Germany, where cutting-edge research and development thrive.
- Revenue Generation: High GDP countries such as the United States, the United Kingdom, and Switzerland are ideal for revenue-driving operations.
- Improving Operating Margins: Look to lower-cost platforms in countries like India, Poland, and Vietnam to optimize your margins.
Transform Your Portfolio Strategy with JLL
JLL works with global pharmaceutical companies to optimize their real estate portfolios, helping you to use locations strategically to fuel your scientific breakthroughs and business success.
This article is posted at jll.com
Please fill out the form to access the content